August 8, 2018
REGENXBIO (RGNX) proposes a $175 M offering
June 14, 2018
Verastem Oncology (VSTM) a registered stock sale
April 4, 2018
Cellectis (CLLS) prices follow-on $175 M ADS offering
February 7, 2018
Adverum Biotechnologies (ADVM) closed $69 M offering
January 22, 2018
Stemline Therapeutics (STML) proposes 3.7 M share offering
January 16, 2018
Intrexon (XON) Prices 6 M share offering at $12.50
December 19, 2017
Northwest Bio (NWBO) Just another Ponzi financing scheme
December 14, 2017
Verastem (VSTM) proposes $25 M offering
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at email@example.com.
Editor and Publisher ... Henry McCusker enters his thirteenth (13th) year at RegMed Investors